What is the recommended dose of intravenous (IV) hydrocortisone (cortisol) for the management of acute exacerbation of asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Hydrocortisone Dosing for Acute Asthma Exacerbation

For acute severe asthma exacerbations, administer IV hydrocortisone 200 mg immediately, followed by 200 mg every 6 hours for patients who are seriously ill or vomiting. 1

Initial Dose Selection

The British Thoracic Society guidelines clearly recommend hydrocortisone 200 mg IV as the initial stat dose for acute severe asthma, which can be given alone or in combination with oral prednisolone 30-60 mg. 1 This 200 mg dose is specifically indicated for:

  • Patients with severe asthma features (respiratory rate >25/min, heart rate >110/min, PEF <50% predicted, inability to complete sentences) 1
  • Patients with life-threatening features (PEF <33% predicted, silent chest, cyanosis, bradycardia, confusion, or exhaustion) 1
  • Patients who are vomiting or unable to take oral medications 1

Maintenance Dosing

Continue hydrocortisone 200 mg IV every 6 hours (total 800 mg/24 hours) for patients who remain seriously ill or continue vomiting. 1 This regimen should be maintained until the patient stabilizes and can transition to oral corticosteroids. 1

Evidence Against Lower Doses

While research suggests that lower doses (50-100 mg every 6 hours) may be equally effective 2, 3, the established guideline recommendation of 200 mg should be followed because:

  • Guidelines prioritize safety margins in acute life-threatening situations 1
  • The 200 mg dose has been the standard of care with proven efficacy in severe presentations 1, 4
  • No additional adverse effects occur with the higher dose in the acute setting 2, 3

A Cochrane review found no significant differences between low (≤80 mg/day methylprednisolone equivalent), medium, and high doses, but this should not override guideline recommendations for initial management of severe cases. 3

Route Considerations

IV administration is specifically indicated when:

  • The patient is vomiting or unable to swallow 1
  • Life-threatening features are present 1
  • Immediate systemic delivery is required 1

For patients who can tolerate oral medications and have less severe presentations, oral prednisolone 30-60 mg is equally effective and may be preferred. 5, 6 However, in the emergency setting with severe or life-threatening asthma, IV hydrocortisone 200 mg provides certainty of delivery and rapid systemic availability. 1, 4

Duration and Transition

High-dose IV corticosteroid therapy should continue only until the patient stabilizes, typically not beyond 48-72 hours. 7 Once the patient improves and can take oral medications, transition to oral prednisolone 30-60 mg daily. 1

Critical Monitoring

Reassess PEF and clinical status 15-30 minutes after initial treatment. 1 If no improvement occurs, continue oxygen and steroids while escalating bronchodilator therapy. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Corticosteroids for acute severe asthma in hospitalised patients.

The Cochrane database of systematic reviews, 2000

Guideline

Tratamiento Farmacológico en Crisis Asmática

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oral versus intravenous steroids in acute exacerbation of asthma--randomized controlled study.

The Journal of the Association of Physicians of India, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.